| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $30.2M | +481.2% |
| R&D Expense | $7K | -86.5% |
| SG&A Expense | $3.1M | -31.0% |
| Operating Income | $24.0M | +7299.7% |
| Interest Expense | $11K | +48.8% |
| Pre-tax Income | $24.4M | +100.8% |
| Income Tax | $814K | +360.7% |
| Net Income | $23.6M | +97.0% |
| EPS (Basic) | $2.33 | -4.5% |
| EPS (Diluted) | $2.32 | +0.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $531K | -59.5% |
| Accounts Receivable | $249K | +750.3% |
| Current Assets | $988K | -62.7% |
| Total Assets | $38.1M | +285.8% |
| Current Liabilities | $4.6M | +618.0% |
| Total Liabilities | $6.2M | +149.7% |
| Stockholders' Equity | $31.9M | +331.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.2M | +75.7% |
| Capital Expenditures | $50K | — |
| Investing Cash Flow | -$49K | — |
| Financing Cash Flow | $497K | -90.1% |
| Free Cash Flow | -$1.2M | — |